Biogen

Biogen's reported carbon emissions

Biogen, a Pharmaceutical Preparation Manufacturing company based in the US, is committed to significant greenhouse gas (GHG) emission reductions. **Carbon Emissions Data:** * **2025:** Biogen reported a total of approximately 356,224,000 kg CO2e. This includes Scope 1 emissions of approximately 56,948,000 kg CO2e, Scope 2 emissions (market-based) of approximately 1,507,000 kg CO2e, and Scope 3 emissions of approximately 297,768,000 kg CO2e. * **2024:** Total emissions were approximately 324,178,000 kg CO2e, comprising around 56,611,000 kg CO2e for Scope 1, approximately 507,000 kg CO2e for Scope 2 (market-based), and about 267,104,000 kg CO2e for Scope 3. * **2023:** The company reported total emissions of approximately 361,715,000 kg CO2e, with Scope 1 at about 57,237,000 kg CO2e, Scope 2 (market-based) at approximately 373,000 kg CO2e, and Scope 3 at approximately 304,105,000 kg CO2e. * **2022:** Total emissions were around 499,837,000 kg CO2e, including Scope 1 emissions of approximately 64,867,000 kg CO2e, Scope 2 (market-based) at approximately 335,000 kg CO2e, and Scope 3 emissions of about 434,635,000 kg CO2e. * **2021:** Total reported emissions were approximately 469,909,000 kg CO2e, with Scope 1 emissions at around 63,182,000 kg CO2e, Scope 2 (market-based) at approximately 268,000 kg CO2e, and Scope 3 emissions totalling about 406,442,000 kg CO2e. * **2020:** Biogen's total emissions were approximately 406,139,000 kg CO2e, including Scope 1 emissions of about 57,553,000 kg CO2e, Scope 2 (market-based) at approximately 280,000 kg CO2e, and Scope 3 emissions of roughly 348,911,000 kg CO2e. * **2019:** Total emissions were approximately 491,545,000 kg CO2e, with Scope 1 emissions around 67,031,000 kg CO2e and Scope 2 (market-based) at about 131,000 kg CO2e. * **2018:** Total emissions amounted to approximately 504,862,000 kg CO2e, including Scope 1 emissions of roughly 68,448,000 kg CO2e and Scope 2 (market-based) at approximately 61,000 kg CO2e. * **2017:** Biogen reported total emissions of approximately 544,139,000 kg CO2e, with Scope 1 emissions at about 61,616,000 kg CO2e and Scope 2 (market-based) at around 59,000 kg CO2e. * **2016:** Total emissions were approximately 316,916,000 kg CO2e, with Scope 1 emissions at about 61,970,000 kg CO2e and Scope 2 (market-based) at approximately 155,000 kg CO2e. * **2015:** The company reported total emissions of about 322,725,000 kg CO2e, including Scope 1 emissions of approximately 60,179,000 kg CO2e and Scope 2 (market-based) at around 187,000 kg CO2e. * **2014:** Total emissions were approximately 291,944,000 kg CO2e, with Scope 1 emissions at about 55,965,000 kg CO2e and Scope 2 (market-based) at approximately 390,000 kg CO2e. **Climate Commitments and Reduction Targets:** Biogen has established ambitious climate targets aligned with the Science Based Targets initiative (SBTi), demonstrating a commitment to decarbonisation across its value chain. * **Net-Zero Ambition:** Biogen aims to achieve net-zero GHG emissions across its entire value chain by 2045. * **Near-Term Targets:** * A reduction of 55% in absolute Scope 1 and 2 GHG emissions by 2032, using a 2019 baseline. * The company also aims for 80% of its suppliers, by spend, for purchased goods and services and capital goods to have science-based targets by 2025. * Additionally, Biogen aims to reduce its Scope 1 and 2 emissions to near zero by the middle of the current decade (2025). * A specific target to achieve net-zero market-based Scope 2 emissions has been set for 2030. * **Long-Term Targets:** * A 100% reduction in absolute Scope 1 and 2 GHG emissions by 2040 from a 2019 baseline. * A significant reduction of 90% in absolute Scope 3 GHG emissions by 2045 from a 2019 baseline. * An ambition to eliminate emissions within its operations by 2040 and achieve a net-zero supply chain by 2045. These commitments reflect Biogen's strategic approach to addressing climate change and its impact on the pharmaceutical industry.